Status:
COMPLETED
Measurements of Myocardial Relaxation Time by MRI During Respiration
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Heart Transplantation
Eligibility:
All Genders
Phase:
NA
Brief Summary
Measurement of T2 transversal relaxation time by magnetic resonance has a major interest in cardiac imagery. It has been initially used for quantitative evaluation of heart viability and more recently...
Eligibility Criteria
Inclusion
- To have had a heart transplant, whenever
- To have an MRI scan of heart with measurement of T2 relaxation time (whatever the reason for examination)
- Major
- To be aware and cooperative
- Affiliation to social security plan
- To have given written consent after having received oral and written, clear and intelligible information
Exclusion
- All contraindications to MRI (implantable defibrillator, cochlear implant, neurosurgical clip, intraorbital or encephalic metallic foreign body, endoprosthesis installed since less than 4 weeks, osteosynthesis materials installed since less than 6 weeks…)
- Instable hemodynamic status, acute respiratory failure, uncertain general status or necessity of continuous monitoring incompatible with MRI examination
- Minors or being under juridical protection or absence of social security
- Refusal or impossibility of informed consent of patient
Key Trial Info
Start Date :
August 31 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2012
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03234205
Start Date
August 31 2011
End Date
December 19 2012
Last Update
August 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy Brabois
Vandœuvre-lès-Nancy, France